[Rules of management and treatment the patients with recurrent hepatitis C after liver transplantation].
Simon
Krzysztof
K
Katedra i Klinika Chorób Zakaźnych, Chorób Watroby i Nabytych Niedoborów Odpornościowych we Wrocławiu.
Pazgan-Simon
Monika
M
D000998:Antiviral Agents / Q000494:pharmacology; D006084:Graft Rejection / Q000453:epidemiology / Q000473:pathology / Q000517:prevention & control; D006526:Hepatitis C / Q000188:drug therapy* / Q000453:epidemiology* / Q000601:surgery / Q000821:virology; D018937:Hepatitis C Antibodies / Q000627:therapeutic use; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use; D016031:Liver Transplantation / Q000009:adverse effects*; D012367:RNA, Viral / Q000097:blood / Q000302:isolation & purification; D012254:Ribavirin / Q000627:therapeutic use*; D055502:Secondary Prevention
D000998:Antiviral Agents; D018937:Hepatitis C Antibodies; D016898:Interferon-alpha; D012367:RNA, Viral; D012254:Ribavirin